TScan Therapeutics Revenue
Biotechnology Research • 
Waltham, Massachusetts, United States • 201-500 Employees
TScan Therapeutics revenue & valuation
| Annual revenue | $6,961,000 |
| Revenue per employee | $34,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $22,300,000 |
| Total funding | $292,500,000 |
Key Contacts at TScan Therapeutics
Zhonghua Zhu
Associate Director, Process Development
Elisaveta Todorova
Associate Director, Process Development And Technology Innovation
Dong Xu
Associate Director, Cell Therapy Analytical Development
Peter Horton
Senior Director Supply Chain
Gavin Macbeath
Member Board Of Directors
Megan Mckennedy
Senior Director, Controller
Sonal Jangalwe
Associate Director, New Technology & Product Development
Patrick Hoell
Senior Director, It & Security
Sylvia Morrison
Associate Director, Legal Operations
Joyce Lin
Director Of Cmc Regulatory Affairs
Company overview
| Headquarters | 830 Winter St, Waltham, Massachusetts 02451, US |
| Phone number | +18573999500 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Tcr-T Cell Therapy |
| Founded | 2018 |
| Employees | 201-500 |
| Socials |
TScan Therapeutics Email Formats
TScan Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@tscan.com), used 87.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@tscan.com | 87.2% |
{first initial}{last name} | jdoe@tscan.com | 12.2% |
About TScan Therapeutics
TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics is a fully integrated, next-generation TCR-T cell therapy company. Founded in 2018, TScan’s platform was developed by Stephen Elledge, Ph.D., and Tomasz Kula, Ph.D., at Brigham and Women’s Hospital and Harvard Medical School. TScan’s transformative platform enables rapid discovery of TCRs and targets for engineered T cell therapy. This technology is extremely versatile and is applicable across multiple therapeutic areas beyond cancers, including autoimmune disorders and infectious diseases.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
TScan Therapeutics has 108 employees across 14 departments.
Departments
Number of employees
Funding Data
Explore TScan Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
TScan Therapeutics Tech Stack
Discover the technologies and tools that power TScan Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Form builders
WordPress plugins
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
Blogs
Widgets
Analytics
Australia
Frequently asked questions
4.8
40,000 users
